The evolution of brachytherapy for prostate cancer

NG Zaorsky, BJ Davis, PL Nguyen… - Nature Reviews …, 2017 - nature.com
Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

RETRACTED: Recommandations françaises du Comité de Cancérologie de l'AFU–Actualisation 2018–2020: cancer de la prostate

F Rozet, C Hennequin, JB Beauval, P Beuzeboc… - Progrès en urologie, 2018 - Elsevier
Author links open overlay panel F. Rozet ab, C. Hennequin ac, J.-B. Beauval ad, P.
Beuzeboc ae, L. Cormier af, G. Fromont-Hankard ag, P. Mongiat-Artus ah, G. Ploussard ai …

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

DP Dearnaley, G Jovic, I Syndikus, V Khoo… - The lancet …, 2014 - thelancet.com
Background The aim of this trial was to compare dose-escalated conformal radiotherapy
with control-dose conformal radiotherapy in patients with localised prostate cancer …

Impact of radiation therapy dose escalation on prostate cancer outcomes and toxicities

NG Zaorsky, SW Keith, T Shaikh… - American journal of …, 2018 - journals.lww.com
Objectives: Freedom from biochemical failure (FFBF) is a common primary outcome of
randomized-controlled trials of prostate cancer (PCa). We aimed to determine how …

Long-term toxicity and health-related quality of life after single-fraction high dose rate brachytherapy boost and hypofractionated external beam radiotherapy for …

N Shahid, A Loblaw, HT Chung, P Cheung… - Clinical Oncology, 2017 - Elsevier
Aims To report health-related quality of life (HRQOL) and toxicity in prostate cancer patients
treated with single-fraction high dose rate (HDR) brachytherapy boost and external beam …

Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer

NG Zaorsky, T Shaikh, CT Murphy, MA Hallman… - Cancer treatment …, 2016 - Elsevier
We review radiation therapy (RT) options available for prostate cancer, including external
beam (EBRT; with conventional fractionation, hypofractionation, stereotactic body RT …

Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis

NG Zaorsky, CT Lee, E Zhang, SW Keith… - Radiotherapy and …, 2017 - Elsevier
Purpose To characterize the cosmetic outcomes and local recurrence (LR) rates of various
hypofractionated radiation therapy (RT) regimens for skin basal and squamous cell cancers …

Recommandations en onco-urologie 2016-2018 du CCAFU: Cancer de la prostate

F Rozet, C Hennequin, JB Beauval, P Beuzeboc… - Progrès en urologie, 2016 - Elsevier
Objectives The purpose of the guidelines national committee CCAFU was to propose
updated french guidelines for localized and metastatic prostate cancer (PCa). Methods A …

Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy

T Wang, RH Press, M Giles, AB Jani… - The British journal of …, 2019 - academic.oup.com
Objective: The purpose of this study is to investigate the dosimetric feasibility of delivering
focal dose to multiparametric (mp) MRI-defined DILs in CT-based high-dose-rate (HDR) …

Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy

NG Zaorsky, T Shaikh, K Ruth, P Sharda… - Clinical genitourinary …, 2017 - Elsevier
Background The purpose of the study was to determine the effect of type 2 diabetes mellitus
(T2DM) on outcomes and toxicities among men with localized prostate cancer receiving …